Modifications in Conventional Tablet Compaction Technologies for Developing Fast Dissolving/ Disintegrating Tablets

2007 ◽  
Vol 96 (2) ◽  
pp. 351-360 ◽  
Author(s):  
Noha Elkhider ◽  
K.L.Andrew Chan ◽  
Sergei G. Kazarian

2009 ◽  
Vol 12 (1) ◽  
pp. 129 ◽  
Author(s):  
Zhihong Zhang ◽  
Bo Peng ◽  
Xinggang Yang ◽  
Chao Wang ◽  
Guangmei Sun ◽  
...  

PURPOSE. Find a novel delivery system for oral administration of drugs that have absorption window in the upper part of gastrointestinal (GI) track. METHODS. Dipyridamole was chosen as the model drug. A novel system, which combined the osmotic pump controlled release system and the floating system, was designed; matrix tablets (MT) were prepared for compares. The effects of pH, temperature and hydrodynamic conditions on drug release and the floating behavior of floating osmotic pump system (FOP) were investigated. In vivo evaluation was performed by a three-crossover study in six Beagle dogs relative to the conventional tablet (CT). Cumulative percent input in vivo was compared with that of in vitro release profiles. RESULTS. Floating behavior of FOP, drug releases from FOP and MT were sensitive to pH of dissolution media but not sensitive to temperature; the release of dipyridamole from MT was influenced by stirring rate while drug release from FOP was not. AUC of FOP was larger than MT and CT. The linear correlations between fraction absorbed in vivo and fraction dissolved in vitro was established for FOP-a true zero-order release formula, whereas only a nonlinear correlation was obtained for MT. CONCLUTIONS. FOP could be a novel way for the oral administration for drugs like dipyridamole.


2017 ◽  
Vol 15 (2) ◽  
pp. 167-172
Author(s):  
SB Shirsand ◽  
RT Gumate ◽  
V Jonathan ◽  
Shailashri

In the present study, novel co-processed superdisintegrants were developed by spray drying method using microcrystalline cellulose and mannitol in different ratios (1:1, 1:2 and 1:3) for use in the fast dissolving tablet formulations. The developed excipients were evaluated for angle of repose, Carr’s index and Hausner’s ratio in comparison with physical mixture of superdisintegrants. The angle of repose of the developed excipients was found to be < 30o, Carr’s index in the range of 9-15 % and Hausner’s ratio in the range of 1.12-1.16. Fast dissolving tablets of glibenclamide were prepared using the above co-processed superdisintegrants and evaluated for pre-compression and post-compression parameters. Based on in vitro dispersion time (approximately 22.23 sec), promising formulation MCM3 was tested for in vitro drug release pattern in pH 6.8 phosphate buffer and stability (at 400C/75 % RH for 3 months), drug excipients interaction (IR spectroscopy) were studied. Among the designed formulations, the formulation (MCM3) containing 8 % w/w of co-processed superdisintegrant (1:3 mixture of microcrystalline cellulose and mannitol) emerged as the overall best formulation (t50% 1.6 min) based on drug release characteristics in pH 6.8 phosphate buffer compared to commercial conventional tablet formulation (t50% 6 min). Stability studies on promising formulation indicated that there were no significant changes in drug content and in vitro dispersion time (p<0.05).Dhaka Univ. J. Pharm. Sci. 15(2): 167-172, 2016 (December)


2014 ◽  
Vol 57 ◽  
pp. 232-239 ◽  
Author(s):  
Philip Carsten Christophersen ◽  
Martin Lau Christiansen ◽  
Rene Holm ◽  
Jakob Kristensen ◽  
Jette Jacobsen ◽  
...  

1980 ◽  
Vol 8 (2) ◽  
pp. 148-152 ◽  
Author(s):  
H K Basu ◽  
C Edwards

A multicentre clinical trial comparing a novel formulation (the Paper Pill) of a combined oral contraceptive containing 30 μg ethinyloestradiol and 150 μg levonorgestrel with a conventional tablet formulation (Microgynon 30) has been carried out in 336 women over 6 cycles. There were no pill failures in women taking either preparation with one exception in the Microgynon 30 group which was due to poor patient compliance. Cycle control judged by cycle length, duration and amount of withdrawal bleeding and the incidence of intermenstrual bleeding was good in both groups. The number of adverse effects was slightly less in the Paper Pill group and fewer withdrawals for medical reasons were noted than in the Microgynon 30 group. A questionnaire showed that the Paper Pill was accepted well by the majority of women in the trial.


1987 ◽  
Vol 27 (4) ◽  
pp. 325-329 ◽  
Author(s):  
Teck L. Ling ◽  
James P. Yee ◽  
Albert Cohen ◽  
Charles Hsiao ◽  
Mario A. Gonzalez ◽  
...  

2010 ◽  
Vol 202 (1-3) ◽  
pp. 46-54 ◽  
Author(s):  
Tuhin Sinha ◽  
Rahul Bharadwaj ◽  
Jennifer S. Curtis ◽  
Bruno C. Hancock ◽  
Carl Wassgren

Sign in / Sign up

Export Citation Format

Share Document